Elite Pharmaceuticals, Inc.: 10-Q filed 2011-11-14
What Elite Pharmaceuticals, Inc. reported in its quarterly report filed 2011-11-14 (fiscal Q2 2011): 35 published measures, 100 facts as tagged in accession 0001144204-11-063703.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2011-11-14
- Fiscal period
- fiscal Q2 2011
- Accession
- 0001144204-11-063703 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Elite Pharmaceuticals, Inc. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-09-30 | 10,834,689 | USD | |
| At 2011-03-31 | 11,787,862 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-09-30 | 34,522,609 | USD | |
| At 2011-03-31 | 29,659,142 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-09-30 | -23,687,920 | USD | |
| At 2011-03-31 | -17,871,280 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-09-30 | 1,339,078 | USD | |
| At 2011-03-31 | 1,825,858 | USD | |
| At 2010-09-30 | 593,853 | USD | |
| At 2010-03-31 | 578,187 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-07-01 to 2011-09-30 | 13,919,321 | USD | 92 |
| 2011-04-01 to 2011-09-30 | -16,814,105 | USD | 183 |
| 2010-07-01 to 2010-09-30 | 1,864,224 | USD | 92 |
| 2010-04-01 to 2010-09-30 | -2,905,171 | USD | 183 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-04-01 to 2011-09-30 | -230,333 | USD | 183 |
| 2010-04-01 to 2010-09-30 | 354,788 | USD | 183 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-04-01 to 2011-09-30 | 118,695 | USD | 183 |
| 2010-04-01 to 2010-09-30 | -53,689 | USD | 183 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-04-01 to 2011-09-30 | -375,138 | USD | 183 |
| 2010-04-01 to 2010-09-30 | -285,433 | USD | 183 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-09-30 | -131,675,134 | USD | |
| At 2011-03-31 | -114,861,029 | USD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-07-01 to 2011-09-30 | 248,247,253 | shares | 92 |
| 2011-04-01 to 2011-09-30 | 240,189,326 | shares | 183 |
| 2010-07-01 to 2010-09-30 | 92,367,680 | shares | 92 |
| 2010-04-01 to 2010-09-30 | 89,760,532 | shares | 183 |
Diluted weighted-average shares
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-07-01 to 2011-09-30 | 454,162,476 | shares | 92 |
| 2011-04-01 to 2011-09-30 | 240,189,326 | shares | 183 |
| 2010-07-01 to 2010-09-30 | 299,999,783 | shares | 92 |
| 2010-04-01 to 2010-09-30 | 89,760,532 | shares | 183 |
Basic earnings per share
Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-07-01 to 2011-09-30 | 0.06 | USD/shares | 92 |
| 2011-04-01 to 2011-09-30 | -0.07 | USD/shares | 183 |
| 2010-07-01 to 2010-09-30 | 0.02 | USD/shares | 92 |
| 2010-04-01 to 2010-09-30 | -0.03 | USD/shares | 183 |
Diluted earnings per share
Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-07-01 to 2011-09-30 | 0.03 | USD/shares | 92 |
| 2011-04-01 to 2011-09-30 | -0.07 | USD/shares | 183 |
| 2010-07-01 to 2010-09-30 | 0.01 | USD/shares | 92 |
| 2010-04-01 to 2010-09-30 | -0.03 | USD/shares | 183 |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-07-01 to 2011-09-30 | 0 | USD | 92 |
| 2011-04-01 to 2011-09-30 | 2,500 | USD | 183 |
| 2010-07-01 to 2010-09-30 | 1,040 | USD | 92 |
| 2010-04-01 to 2010-09-30 | 3,120 | USD | 183 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-09-30 | 4,243,696 | USD | |
| At 2011-03-31 | 4,118,274 | USD |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-07-01 to 2011-09-30 | -591,602 | USD | 92 |
| 2011-04-01 to 2011-09-30 | -928,136 | USD | 183 |
| 2010-07-01 to 2010-09-30 | -136,807 | USD | 92 |
| 2010-04-01 to 2010-09-30 | -231,496 | USD | 183 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-09-30 | 2,078,494 | USD | |
| At 2011-03-31 | 3,147,359 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-07-01 to 2011-09-30 | 57,931 | USD | 92 |
| 2011-04-01 to 2011-09-30 | 115,301 | USD | 183 |
| 2010-07-01 to 2010-09-30 | 57,737 | USD | 92 |
| 2010-04-01 to 2010-09-30 | 115,806 | USD | 183 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-09-30 | 4,473,505 | USD | |
| At 2011-03-31 | 4,669,315 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-09-30 | 252,659 | USD | |
| At 2011-03-31 | 571,667 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-07-01 to 2011-09-30 | 789,403 | USD | 92 |
| 2011-04-01 to 2011-09-30 | 1,690,544 | USD | 183 |
| 2010-07-01 to 2010-09-30 | 565,829 | USD | 92 |
| 2010-04-01 to 2010-09-30 | 1,080,767 | USD | 183 |
Net inventory
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-09-30 | 382,239 | USD | |
| At 2011-03-31 | 616,362 | USD |
Gross profit
Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-07-01 to 2011-09-30 | 197,801 | USD | 92 |
| 2011-04-01 to 2011-09-30 | 762,408 | USD | 183 |
| 2010-07-01 to 2010-09-30 | 429,022 | USD | 92 |
| 2010-04-01 to 2010-09-30 | 849,271 | USD | 183 |
Cost of revenue
Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-07-01 to 2011-09-30 | 76,331 | USD | 92 |
| 2011-04-01 to 2011-09-30 | 501,700 | USD | 183 |
| 2010-07-01 to 2010-09-30 | 565,624 | USD | 92 |
| 2010-04-01 to 2010-09-30 | 977,295 | USD | 183 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-07-01 to 2011-09-30 | 198,212 | USD | 92 |
| 2011-04-01 to 2011-09-30 | 643,709 | USD | 183 |
| 2010-07-01 to 2010-09-30 | 150,436 | USD | 92 |
| 2010-04-01 to 2010-09-30 | 315,444 | USD | 183 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-09-30 | 254,779,074 | shares | |
| At 2011-03-31 | 180,545,657 | shares |
Accumulated depreciation on property, plant and equipment
Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-09-30 | 4,427,377 | USD | |
| At 2011-03-31 | 4,189,618 | USD |
Net intangible assets excluding goodwill
Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-09-30 | 613,833 | USD | |
| At 2011-03-31 | 597,556 | USD |
Other noncurrent liabilities
Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-09-30 | 75,163 | USD | |
| At 2011-03-31 | 75,463 | USD |
Prepaid expenses and other current assets
Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-09-30 | 104,518 | USD | |
| At 2011-03-31 | 133,472 | USD |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-07-01 to 2011-09-30 | 476,897 | USD | 92 |
| 2011-04-01 to 2011-09-30 | 801,494 | USD | 183 |
| 2010-07-01 to 2010-09-30 | 379,104 | USD | 92 |
| 2010-04-01 to 2010-09-30 | 635,345 | USD | 183 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-04-01 to 2011-09-30 | 244,796 | USD | 183 |
| 2010-04-01 to 2010-09-30 | 241,626 | USD | 183 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-07-01 to 2011-09-30 | 14,510,923 | USD | 92 |
| 2011-04-01 to 2011-09-30 | -15,883,469 | USD | 183 |
| 2010-07-01 to 2010-09-30 | 2,002,071 | USD | 92 |
| 2010-04-01 to 2010-09-30 | -2,670,555 | USD | 183 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-04-01 to 2011-09-30 | -319,008 | USD | 183 |
| 2010-04-01 to 2010-09-30 | 36,372 | USD | 183 |
Change in inventories
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-04-01 to 2011-09-30 | -234,123 | USD | 183 |
| 2010-04-01 to 2010-09-30 | -40,120 | USD | 183 |
Inspect the source
- Entity
- Elite Pharmaceuticals, Inc. / CIK 0001053369
- Captured
- 2026-09-20T05:17:33.154Z
- SEC response SHA-256
b91e0331a01f96870ee44e841f605bd504e1bc784022b77f374cfe93dc363314
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001053369.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))